Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
批准号:
10826448
负责人:
Agnel Sfeir
金额:
$54.29万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-30 至 2028-05-31
关键词:
AgingBase PairingBiogenesisBrainCell AgingCell physiologyCellsChronic progressive external ophthalmoplegiaDNA RepairDiseaseDrosophila genusEpithelial CellsFibroblastsFunctional disorderGeneticGenomeGenome StabilityGenomic InstabilityInterphase CellKearns-Sayre syndromeLinkMammalian CellMethodologyMethodsMitochondriaMitochondrial DNAMitosisMonitorMuscleMuscle CellsMutateNeuronsNuclearOutputOxidative PhosphorylationPathologyPathway interactionsPhysiologicalPositioning AttributeProcessSeriesSomatic CellSpecificityTestingTissuesage relatedbiological adaptation to stresscell typedimerembryonic stem cellexperiencegenome integrityheteroplasmyinsightmitochondrial DNA mutationmitochondrial dysfunctionmitochondrial genomemodel organismmutantnovelparticlepostmitoticpreventreconstitutionrepairedrespiratoryresponsetooltranscription activator-like effector nucleasestranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
The most common mitochondrial DNA (mtDNA) abnormality is a deletion of 4977 base pairs
called the common deletion (CD), associated with mitochondrial pathologies and widespread in
aging. The CD primarily manifests in the brain and muscles when deleted molecules exceed
60% of total copies, known as heteroplasmy. However, the mechanisms that cause harmful
deletions and why neuronal and muscle cells are particularly vulnerable to CD remain unclear.
Major obstacles to studying the CD is the lack of tools to manipulate mtDNA and the inability to
generate the CD in a controlled manner. Here, we developed a series of methodologies to
overcome these barriers. Specifically, we generated an inducible quasi-dimeric TALEN that
generates the CD in isogenic settings and at defined heteroplasmy states. With this tool, we will
establish low, medium, and high levels of CD heteroplasmy in embryonic stem cells that we will
then differentiate into muscle, neuronal, and fibroblast cells and elucidate the consequence of
this harmful deletion in a cell-type-specific manner and its impact on cellular aging. Furthermore,
we will explore the cell-type-specific distribution of CD, Identifying the pathways that sustain
mutant mtDNA propagation in post-mitotic cells while promoting its elimination in dividing cells.
Combining novel genetic tools with extensive experience in genome stability will resolve the
long-standing mystery of preferential mutant mtDNA propagation in post-mitotic cells and have
significant implications for numerous mitochondrial pathologies and aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Define the Role of POT1 Mutation in Genome Instability and Cancer
-
批准号:10221642
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10379672
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Define the Role of POT1 Mutation in Genome Instability and Cancer
-
批准号:10379657
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10576792
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10320939
-
项目类别:
-
资助金额:$39.34万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10090458
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2019
-
负责人:Agnel Sfeir
-
依托单位:
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac
-
批准号:9298637
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2014
-
负责人:Agnel Sfeir
-
依托单位:
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac
-
批准号:8749789
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2014
-
负责人:Agnel Sfeir
-
依托单位:
海外基金